C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
12/2011
12/22/2011	US20110313681 Biomarkers for peripheral artery disease
12/22/2011	US20110313140 Process for producing coelenteramide or an analog thereof
12/22/2011	US20110313133 Albumin variants and conjugates
12/22/2011	US20110313132 Process for the production of preformed conjugates of albumin and a therapeutic agent
12/22/2011	US20110313131 Reversed phase hplc purification of a glp-1 analogue
12/22/2011	US20110313130 Bifunctional chelating agents
12/22/2011	US20110313045 Histone deacetylases, and uses related thereto
12/22/2011	US20110313029 Diagnostic and therapeutic uses of gnptab, gnptg, and nagpa in stuttering
12/22/2011	US20110313026 Dna and proteins or peptides specific of bacteria of the neisseria meningitidis species, methods for obtaining them and biological applications thereof
12/22/2011	US20110312922 EDTA Resistant S100A12 Complexes (ERAC)
12/22/2011	US20110312899 HDL Particles for Delivery of Nucleic Acids
12/22/2011	US20110312896 Inhibitors of bcl-2
12/22/2011	US20110312893 Method for isolating neural cells with tenascin-r compounds
12/22/2011	US20110312891 Enamel matrix derivative fraction c
12/22/2011	US20110312887 Promoter for regeneration of tendon-bone junction tissue or ligament-bone junction tissue
12/22/2011	US20110312883 Neurturin molecules
12/22/2011	US20110312881 Bifunctional polypeptide compositions and methods for treatment of metabolic and cardiovascular diseases
12/22/2011	US20110312878 Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis
12/22/2011	US20110312872 Norrin in the treatment of diseases associated with an increased tgf-beta activity
12/22/2011	US20110312522 Methods of detection of cancer using peptide profiles
12/22/2011	US20110312514 Method For Determination And Quantification Of Radiation Or Genotoxin Exposure
12/22/2011	US20110312497 Use of hydrophobin as a spreading agent
12/22/2011	US20110312105 Detection system and method for high sensitivity fluorescent assays
12/22/2011	US20110312047 Polypeptides having C4 Dicarboxylic Acid Transporter Activity and Polynucleotides Encoding Same
12/22/2011	US20110312030 Consistent high expression vector containing rep e mutated gene
12/22/2011	US20110311999 Diagnostic prediction of rheumatoid arthritis and systemic lupus erythematosus
12/22/2011	US20110311990 Tetranor-pgem/pgam specific immunogens, antibodies, tracers, assay kits and methods for making same
12/22/2011	US20110311965 Methods of enhancing translocation of charged analytes through transmembrane protein pores
12/22/2011	US20110311615 Novel gp41 antigens
12/22/2011	US20110311586 Materials and methods for respiratory disease control in canines
12/22/2011	US20110311585 Therapeutic compositions and methods for treating HIV including identification and manipulation of particular domains associated with immunogenicity
12/22/2011	US20110311581 Reverse genetics of negative-strand rna viruses in yeast
12/22/2011	US20110311580 Settings for recombinant adenoviral-based vaccines
12/22/2011	US20110311577 Method of producing a vaccine
12/22/2011	US20110311573 Method for Preparing Recombinant Antigen Complex Using Rotavirus Nanoparticle
12/22/2011	US20110311572 Nucleotide and amino acid sequences encoding an exported protein 1 derived from plasmodium vivax and uses thereof
12/22/2011	US20110311571 Methods and compositions for treating and preventing malaria using an invasion ligand directed to a protease-resistant receptor
12/22/2011	US20110311570 Proteins with repetitive bacterial-ig-like (big) domains present in leptospira species
12/22/2011	US20110311569 HIV-1 Peptides, Nucleic Acids, and Compositions and Uses Thereof
12/22/2011	US20110311558 Recombinant Bone Marrow Stromal Antigen-2 in the Treatment of Autoimmune Diseases
12/22/2011	US20110311543 Tumor Antigens BFA5 for Prevention and/or Treatment of Cancer
12/22/2011	US20110311541 Mutant proteins of the f protein of piv-5 and piv-2
12/22/2011	US20110311540 Wisp polypeptides and nucleic acids encoding same
12/22/2011	US20110311539 Diagnosis and treatment of cancer using cancer-testis antigens
12/22/2011	US20110311537 Methods of using il-1 antagonists to treat familial mediterranean fever (fmf)
12/22/2011	US20110311531 Immunotherapy of autoimmune disorders using antibodies which target b-cells
12/22/2011	US20110311530 Truncated baff receptors
12/22/2011	US20110311529 Method for treating a rheumatic disease using a soluble tla4 molecule
12/22/2011	US20110311518 Novel synthetic agonists of tlr9
12/22/2011	US20110311499 Secretion System and Methods for its Use
12/22/2011	US20110311489 Optically-based stimulation of target cells and modifications thereto
12/22/2011	US20110311475 Means and method for the treatment of antibody deficiency diseases based on il-21 and il-21 variants
12/22/2011	US20110311454 Molecules with extended half-lives, compositions and uses thereof
12/22/2011	US20110311446 Peptides that specifically bind hgf receptor (cmet) and uses thereof
12/22/2011	CA2802726A1 Long lasting drug formulations
12/22/2011	CA2802723A1 Detection of epha3 as a marker of the presence of a solid tumor
12/22/2011	CA2802635A1 Peptides as active agents to stabilize biologic barriers
12/22/2011	CA2802599A1 Modified parvovirus having enhanced anti-tumour efficacy
12/22/2011	CA2802485A1 Single chain insulin agonists exhibiting high activity at the insulin receptor
12/22/2011	CA2802471A1 Novel peptides for wound healing
12/22/2011	CA2802351A1 Clostridium taeniosporum spores and spore appendages as surface display hosts, drug delivery devices, and nanobiotechnological structures
12/22/2011	CA2802344A1 Bi-specific antibodies against tim-3 and pd-1 for immunotherapy in chronic immune conditions
12/22/2011	CA2802249A1 Generation of induced pluripotent stem cells from small volumes of peripheral blood
12/22/2011	CA2802072A1 Treatment of coagulopathy with hyperfibrinolysis
12/22/2011	CA2800650A1 Cell-penetrating peptides and uses therof
12/21/2011	EP2397566A1 Methods for the simultaneous detection of HCV antigens and HCV antibodies
12/21/2011	EP2397555A1 Fusion proteins of mycobacterium tuberculosis antigens and their uses
12/21/2011	EP2397554A1 Flowering inhibition
12/21/2011	EP2397553A1 Recombinant vaccines against caligid copepods (sea lice) and antigen sequences thereof
12/21/2011	EP2397552A1 Recombinant vaccines against caligid copepods (sea lice) and antigen sequences thereof
12/21/2011	EP2397549A2 Non-stochastic generation of genetic vaccines and enzymes
12/21/2011	EP2397493A1 Compositions and methods for modulating immune responses
12/21/2011	EP2397492A2 Mutants of angiogenin in Amyotrophic lateral sclerosis
12/21/2011	EP2397491A1 LeaA from Trichoderma reesei
12/21/2011	EP2397490A1 Vaccine constructs and combinations of vaccines designed to improve the breadth of the immune response to diverse strains and clades of HIV
12/21/2011	EP2397489A1 Epitopes, combined epitopes, use of epitopes or their combination, composition, uses of the composition, anti-HIV-I prophylactic vaccines, therapeutic vaccines, method for the identification of epitopes and methods for treatment and prevention
12/21/2011	EP2397154A2 Peptides for desensibilization against allergens
12/21/2011	EP2397151A1 Treatment of vascular complications of diabetes
12/21/2011	EP2397150A1 Biopolymer, implant comprising it and uses thereof
12/21/2011	EP2397031A1 Compositions and methods for modulation of plant cell division
12/21/2011	EP2396659A1 Rbm3 protein in testicular cancer diagnostics and prognostics
12/21/2011	EP2396410A1 Method for producing protein
12/21/2011	EP2396347A2 Albumin variants and conjugates
12/21/2011	EP2396346A1 Rbm3 protein in colorectal cancer prognostics
12/21/2011	EP2396345A1 Antimicrobial peptides based on cmap27
12/21/2011	EP2396344A2 Nucleic acid molecule of a biosynthetic cluster encoding non ribosomal peptide synthases and uses thereof
12/21/2011	EP2396343A2 Modified virus vectors and methods of making and using the same
12/21/2011	EP2396342A2 Mutant ros expression in human cancer
12/21/2011	EP2396084A1 Anti-mst1r antibodies and uses thereof
12/21/2011	EP2396023A2 Short beta-defensin-derived peptides
12/21/2011	EP2396022A1 Molecules able to modulate the expression of at least a gene involved in degradative pathways and uses thereof
12/21/2011	EP2396020A2 Novel antimicrobial peptides
12/21/2011	EP2396017A1 Apolipoprotein a-i mimics
12/21/2011	EP2396011A2 Fibronectin type iii domain based scaffold compositions, methods and uses
12/21/2011	EP2395831A2 Control of plant stress tolerance, water use efficiency and gene expression using novel aba receptor proteins and synthetic agonists
12/21/2011	EP2059525B1 Split-core-particles for the presentation of foreign molecules, especially for vaccine applications, and method for their production
12/21/2011	EP1991584B1 Antibodies against human il-22 and uses therefor
12/21/2011	EP1979374B1 Template-fixed peptidomimetics
12/21/2011	EP1953238B1 Method for screening of substances using GPR40 and secretory phospholipase A2
12/21/2011	EP1770165B1 Dna coding for polypeptide participating in biosynthesis of pladienolide

1 ... 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 ... 2916